1 |
Barrett DM. The effect of oral bethanechol chloride on voiding in female patients with excessive residual urine: a randomized double-blind study. J Urol 1981;126:640-2
DOI
PUBMED
|
2 |
Finkbeiner AE. Is bethanechol chloride clinically effective in promoting bladder emptying? A literature review. J Urol 1985;134:443-9
DOI
PUBMED
|
3 |
Schafer W. Analysis of bladder-outlet function with the linearized passive urethral resistance relation, linPURR, and a disease-specific approach for grading obstruction: from complex to simple. World J Urol 1995;13:47-58
PUBMED
|
4 |
Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the international continence society. Neurourol Urodyn 2002;21:167-78
DOI
ScienceOn
|
5 |
Krane RJ, Olsson CA. Phenoxybenzamine in neurogenic bladder dysfunction. II. Clinical considerations. J Urol 1973; 110:653-6
DOI
PUBMED
|
6 |
Yamanishi T, Yasuda K, Kamai T, Tsujii T, Sakakibara R, Uchiyama T, et al. Combination of a cholinergic drug and an alpha-blocker is more effective than monotherapy for the treatment of voiding difficulty in patients with underactive detrusor. Int J Urol 2004;11:88-96
DOI
ScienceOn
|
7 |
Sullivan J, Abrams P. Alpha-adrenoceptor antagonists in neurogenic lower urinary tract dysfunction. Urology 1999;53(3 Suppl 3a):21-7
DOI
ScienceOn
|
8 |
Downie JW. Bethanechol chloride in urology-a discussion of issues. Neurourol Urodyn 1984;3:211-22
DOI
|
9 |
Khanna OP. Disorders of micturition: neuropharmacologic basis and results of drug therapy. Urology 1976;8:316-28
DOI
ScienceOn
|
10 |
Riedl CR, Stephen RL, Daha LK, Knoll M, Plas E, Pfluger H. Electromotive administration of intravesical bethanechol and the clinical impact on acontractile detrusor management: introduction of a new test. J Urol 2000;164:2108-11
DOI
ScienceOn
|
11 |
Scott MB, Morrow JW. Phenoxybenzamine in neurogenic bladder dysfunction after spinal cord injury. I. Voiding dysfunction. J Urol 1978;119:480-2
DOI
PUBMED
|
12 |
Starr I, Ferguson LK. Beta-methylcholine-urethane. Its action in various normal and abnormal conditions, especially postoperative urinary retention. Am J Med Sci 1940;200:372
DOI
|
13 |
Brown JH, Taylor P. Muscarinic receptor agonists and antagonists. In: Hardman JG, Limbird LE, editors. The pharmacological basis of therapeutics. 9th ed. New York: McGraw-Hill; 1996;141-60
|
14 |
Wein AJ, Malloy TR, Shofer F, Raezer DM. The effects of bethanechol chloride on urodynamic parameters in normal women and in women with significant residual urine volumes. J Urol 1980;124:397-9
DOI
PUBMED
|
15 |
Awad SA. Clinical use of bethanechol. J Urol 1985;134:523-4
DOI
PUBMED
|
16 |
Finkbeiner AE, Bissada NK. Drug therapy for lower urinary tract dysfunction. Urol Clin North Am 1980;7:3-16
PUBMED
|